{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:22:54Z","timestamp":1783380174982,"version":"3.54.6"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Institues on Drug Abuse, United States","award":["DA027845"],"award-info":[{"award-number":["DA027845"]}]},{"DOI":"10.13039\/100007237","name":"University of North Dakota, United States","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007237","id-type":"DOI","asserted-by":"publisher"}]},{"name":"School of Medicine and Health Sciences Seed Grant"},{"name":"National Institutes on Drug Abuse, United States"},{"name":"Intramural Research Program","award":["ZIA DA000389"],"award-info":[{"award-number":["ZIA DA000389"]}]},{"name":"ZIA","award":["DA000610"],"award-info":[{"award-number":["DA000610"]}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation, United States","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"North Dakota EPSCoR Graduate Student Research Assistantship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.neuint.2018.08.008","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T10:29:00Z","timestamp":1534501740000},"page":"34-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Identification of the benztropine analog [125I]GA II 34 binding site on the human dopamine transporter"],"prefix":"10.1016","volume":"123","author":[{"given":"Michael J.","family":"Tomlinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Krout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akula Bala","family":"Pramod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-9474","authenticated-orcid":false,"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Keith","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne A.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2018.08.008_bib1","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1021\/acschemneuro.7b00094","article-title":"The isomeric preference of an atypical dopamine transporter inhibitor contributes to its selection of the transporter conformation","volume":"8","author":"Abramyan","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2018.08.008_bib2","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0960-894X(97)10139-1","article-title":"A novel photoaffinity label for the dopamine transporter based on N-substituted 3\u03b1-[bis(4\u2032-fluorophenyl)methoxy]tropane","volume":"7","author":"Agoston","year":"1997","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuint.2018.08.008_bib3","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","article-title":"Novel N-substituted 3\u03b1-[bis (4\u2019-fluorophenyl) methoxy] tropane analogues: selective ligands for the dopamine transporter","volume":"40","author":"Agoston","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.ne.16.030193.000445","article-title":"Neurotransmitter transporters: recent progress","volume":"16","author":"Amara","year":"1993","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2018.08.008_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nn.2146","article-title":"The binding sites for cocaine and dopamine in the dopamine transporter overlap","volume":"11","author":"Beuming","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2018.08.008_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2010.08.021","article-title":"The binding sites for benztropines and dopamine in the dopamine transporter overlap","volume":"60","author":"Bisgaard","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2018.08.008_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1476-5381.2012.01975.x","article-title":"The solute Carrier 6 family of transporters","volume":"167","author":"Br\u00f6er","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib8","doi-asserted-by":"crossref","first-page":"18524","DOI":"10.1074\/jbc.M112.343681","article-title":"The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters","volume":"287","author":"Bulling","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib9","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1021\/acs.jmedchem.6b01373","article-title":"Novel and high affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) analogues as atypical dopamine transporter inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib10","doi-asserted-by":"crossref","first-page":"40442","DOI":"10.1074\/jbc.M501969200","article-title":"Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms","volume":"280","author":"Cervinski","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib11","doi-asserted-by":"crossref","first-page":"19066","DOI":"10.1074\/jbc.M117.787002","article-title":"Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding","volume":"292","author":"Challasivakanaka","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1471-4159.2004.02835.x","article-title":"Characterization of an allosteric citalopram-binding site at the serotonin transporter","volume":"92","author":"Chen","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2018.08.008_bib13","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.str.2015.09.001","article-title":"Molecular mechanism of dopamine transport by human dopamine transporter","volume":"23","author":"Cheng","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.neuint.2018.08.008_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fneur.2015.00134","article-title":"Insights into the modulation of dopamine transporter function by amphetamine, orphenadrine, and cocaine binding","volume":"6","author":"Cheng","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuint.2018.08.008_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-4159.2004.02386.x","article-title":"Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine","volume":"89","author":"Chen","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2018.08.008_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature17629","article-title":"X-ray structures and mechanism of the human serotonin transporter","volume":"532","author":"Coleman","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/nprot.2013.074","article-title":"Small-molecule ligand docking into comparative models with Rosetta","volume":"8","author":"Combs","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuint.2018.08.008_bib18","doi-asserted-by":"crossref","first-page":"29712","DOI":"10.1074\/jbc.M114.571521","article-title":"Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site","volume":"289","author":"Dahal","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib19","doi-asserted-by":"crossref","first-page":"29712","DOI":"10.1074\/jbc.M114.571521","article-title":"Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site","volume":"289","author":"Dahal","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2018.02.025","article-title":"Replacement treatment during extinction training with the atypical dopamine uptake inhibitor, JHW-007, reduces relapse to methamphetamine seeking","volume":"671","author":"Dassanayake","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2018.08.008_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jmb.2008.11.010","article-title":"RosettaLigand docking with full ligand and receptor flexibility","volume":"385","author":"Davis","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuint.2018.08.008_bib22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.08.008_bib23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1074\/jbc.M113.504654","article-title":"The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport","volume":"289","author":"Felts","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib24","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0804659105","article-title":"Mechanism for alternating access in neurotransmitter transporters","volume":"105","author":"Forrest","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2018.08.008_bib25","doi-asserted-by":"crossref","first-page":"25178","DOI":"10.1074\/jbc.M200294200","article-title":"Dopamine transporters are phosphorylated on N-terminal serines in rat striatum","volume":"277","author":"Foster","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchemneu.2016.10.004","article-title":"Phosphorylation mechanisms in dopamine transporter regulation","volume":"83\u201384","author":"Foster","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuint.2018.08.008_bib27","doi-asserted-by":"crossref","first-page":"29702","DOI":"10.1074\/jbc.M112.367706","article-title":"Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux","volume":"287","author":"Foster","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/mol.65.3.692","article-title":"Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter","volume":"65","author":"Gaffaney","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib29","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.neuint.2018.08.008_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tips.2006.05.003","article-title":"Neurotransmitter transporters: molecular function of important drug targets","volume":"27","author":"Gether","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2018.08.008_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/128_2011_286","article-title":"Photoaffinity labeling in activity-based protein profiling","volume":"324","author":"Geurink","year":"2012","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuropharm.2005.08.011","article-title":"Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation","volume":"49","author":"Gorentla","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2018.08.008_bib33","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0076-6879(67)11029-X","article-title":"[27] the cyanogen bromide reaction","author":"Gross","year":"1967"},{"key":"10.1016\/j.neuint.2018.08.008_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.mp.4000711","article-title":"Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)","volume":"5","author":"Gr\u00fcnhage","year":"2000","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuint.2018.08.008_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.tpj.6500106","article-title":"Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders","volume":"2","author":"Hahn","year":"2002","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neuint.2018.08.008_bib36","doi-asserted-by":"crossref","first-page":"37052","DOI":"10.1074\/jbc.M305514200","article-title":"Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I","volume":"278","author":"Henry","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib37","doi-asserted-by":"crossref","first-page":"30823","DOI":"10.1074\/jbc.M111.250308","article-title":"A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport","volume":"286","author":"Henry","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.neuint.2018.08.008_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.117.241109","article-title":"\u03c3 receptor effects of N-Substituted benztropine analogs: implications for antagonism of cocaine self-administration","volume":"362","author":"Hiranita","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.08.008_bib40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.08.008_bib41","doi-asserted-by":"crossref","first-page":"11250","DOI":"10.1074\/jbc.M116.774075","article-title":"The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats","volume":"292","author":"Hong","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/211969a0","article-title":"Simple allosteric model for membrane pumps","volume":"211","author":"Jardetzky","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002130000667","article-title":"Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents","volume":"154","author":"Katz","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2018.08.008_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/164_2016_94","article-title":"A role for sigma receptors in stimulant self-administration and addiction","volume":"244","author":"Katz","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-3565(24)37956-X","article-title":"Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine","volume":"288","author":"Katz","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.08.008_bib46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.103.060525","article-title":"Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands","volume":"309","author":"Katz","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.08.008_bib47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0091-3057(96)00441-8","article-title":"Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine","volume":"57","author":"Katz","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2018.08.008_bib48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2014.03.031","article-title":"Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine","volume":"76","author":"Kohut","year":"2014","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuint.2018.08.008_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002246","article-title":"Unbiased simulations reveal the inward-facing conformation of the human serotonin transporter and Na(+) ion release","volume":"7","author":"Kolds\u00f8","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neuint.2018.08.008_bib50","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/anie.199512961","article-title":"Recent trends in photoaffinity labeling","volume":"34","author":"Kotzyba-Hibert","year":"1995","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.neuint.2018.08.008_bib51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature10737","article-title":"X-ray structures of LeuT in substrate-free outward-open and apo inward-open states","volume":"481","author":"Krishnamurthy","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2018.08.008_bib53","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bcp.2017.07.015","article-title":"Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs","volume":"142","author":"Krout","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","article-title":"The dopamine hypothesis of the reinforcing properties of cocaine","volume":"14","author":"Kuhar","year":"1991","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2018.08.008_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1474-4422(10)70269-6","article-title":"Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study","volume":"10","author":"Kurian","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2018.08.008_bib56","first-page":"1595","article-title":"Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia","volume":"119","author":"Kurian","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2018.08.008_bib57","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bph.13411","article-title":"Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporter","volume":"173","author":"Larsen","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/syn.21877","article-title":"Cocaine occupancy of sigma1 receptors and dopamine transporters in mice","volume":"70","author":"Lever","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2018.08.008_bib59","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1074\/jbc.M304755200","article-title":"Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding","volume":"279","author":"Loland","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1074\/jbc.M112.407874","article-title":"Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding","volume":"288","author":"Moritz","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/syn.20048","article-title":"Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter","volume":"53","author":"Nandi","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2018.08.008_bib62","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1021\/jm00041a002","article-title":"Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles","volume":"37","author":"Newman","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib63","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1021\/jm00020a006","article-title":"Novel 4\u2019-substituted and 4',4''-disubstituted 3.alpha.-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors","volume":"38","author":"Newman","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/med.10014","article-title":"Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic\u2014a focus on analogues of benztropine and rimcazole","volume":"22","author":"Newman","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuint.2018.08.008_bib65","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/jpet.105.084376","article-title":"Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter","volume":"314","author":"Nightingale","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.08.008_bib66","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1124\/mol.107.043679","article-title":"Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites","volume":"73","author":"Parnas","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib67","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1124\/mol.107.043679","article-title":"Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites","volume":"73","author":"Parnas","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib68","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nsmb.3029","article-title":"X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine","volume":"22","author":"Penmatsa","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuint.2018.08.008_bib69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature12533","article-title":"X-ray structure of dopamine transporter elucidates antidepressant mechanism","volume":"503","author":"Penmatsa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib70","doi-asserted-by":"crossref","first-page":"39316","DOI":"10.1074\/jbc.M112.371765","article-title":"Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter","volume":"287","author":"Plenge","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","article-title":"SLC6 transporters: structure, function, regulation, disease association and therapeutics","volume":"34","author":"Pramod","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuint.2018.08.008_bib72","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1073\/pnas.0811322106","article-title":"Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation","volume":"106","author":"Quick","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2018.08.008_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jchemneu.2017.01.002","article-title":"Palmitoylation mechanisms in dopamine transporter regulation","volume":"83\u201384","author":"Rastedt","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuint.2018.08.008_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuint.2018.08.008_bib75","doi-asserted-by":"crossref","first-page":"29012","DOI":"10.1074\/jbc.M011785200","article-title":"The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter","volume":"276","author":"Reith","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib76","doi-asserted-by":"crossref","first-page":"PL17","DOI":"10.1016\/0024-3205(90)90466-5","article-title":"High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development","volume":"46","author":"Rothman","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2018.08.008_bib77","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.114.222299","article-title":"Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency","volume":"353","author":"Rothman","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.08.008_bib78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcp.2007.08.007","article-title":"Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction","volume":"75","author":"Rothman","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00424-013-1410-1","article-title":"The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction","volume":"466","author":"Rudnick","year":"2013","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"10.1016\/j.neuint.2018.08.008_bib81","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/s41467-017-02087-x","article-title":"The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission","volume":"8","author":"Sambo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2018.08.008_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025790","article-title":"The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors","volume":"6","author":"Schmitt","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2018.08.008_bib83","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1471-4159.2008.05667.x","article-title":"Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties","volume":"107","author":"Schmitt","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2018.08.008_bib84","series-title":"The PyMOL Molecular Graphics System, Version 1.8","author":"Schrodinger","year":"2015"},{"key":"10.1016\/j.neuint.2018.08.008_bib85","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2016.09.006","article-title":"The external gate of the human and Drosophila serotonin transporters requires a basic\/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux","volume":"120","author":"Sealover","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016350","article-title":"The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter","volume":"6","author":"Shan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2018.08.008_bib87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2008.05.008","article-title":"The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site","volume":"30","author":"Shi","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuint.2018.08.008_bib88","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.1166777","article-title":"A competitive inhibitor traps LeuT in an open-to-out conformation","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuint.2018.08.008_bib89","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nature06038","article-title":"Antidepressant binding site in a bacterial homologue of neurotransmitter transporters","volume":"448","author":"Singh","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib90","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nature06038","article-title":"Antidepressant binding site in a bacterial homologue of neurotransmitter transporters","volume":"448","author":"Singh","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib91","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2018.08.008_bib92","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1074\/jbc.M115.692012","article-title":"Two Na+ sites control conformational change in a neurotransmitter transporter homolog","volume":"291","author":"Tavoulari","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib93","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2018.32.1_supplement.680.1","article-title":"Photoaffinity-mediated identification of a third citalopram analog binding site of the serotonin transporter","volume":"32","author":"Tomlinson","year":"2018","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2018.08.008_bib94","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuropharm.2017.12.006","article-title":"Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats","volume":"131","author":"Tunstall","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2018.08.008_bib95","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/jpet.105.085829","article-title":"Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue","volume":"314","author":"Ukairo","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.08.008_bib96","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0026-895X(25)08605-5","article-title":"Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping","volume":"47","author":"Vaughan","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2018.08.008_bib97","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1523\/JNEUROSCI.19-02-00630.1999","article-title":"Differential binding of tropane-based photoaffinity ligands on the dopamine transporter","volume":"19","author":"Vaughan","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.08.008_bib98","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2018.08.008_bib99","doi-asserted-by":"crossref","first-page":"15541","DOI":"10.1074\/jbc.272.24.15541","article-title":"Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes","volume":"272","author":"Vaughan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib100","doi-asserted-by":"crossref","first-page":"21672","DOI":"10.1074\/jbc.271.35.21672","article-title":"Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis","volume":"271","author":"Vaughan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib101","doi-asserted-by":"crossref","first-page":"8915","DOI":"10.1074\/jbc.M610633200","article-title":"Localization of cocaine analog [125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter","volume":"282","author":"Vaughan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.08.008_bib102","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature14431","article-title":"Neurotransmitter and psychostimulant recognition by the dopamine transporter","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib103","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature03978","article-title":"Crystal structure of a bacterial homologue of Na+\/Cl--dependent neurotransmitter transporters","volume":"437","author":"Yamashita","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib104","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/npp.2017.41","article-title":"The novel modafinil analog, JJC8-016, as a potential cocaine abuse pharmacotherapeutic","volume":"42","author":"Zhang","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2018.08.008_bib105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature09971","article-title":"Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2018.08.008_bib106","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1147614","article-title":"LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake","volume":"317","author":"Zhou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuint.2018.08.008_bib107","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nsmb.1602","article-title":"Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures","volume":"16","author":"Zhou","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuint.2018.08.008_bib108","doi-asserted-by":"crossref","first-page":"10172","DOI":"10.1021\/acs.jmedchem.7b01454","article-title":"Structure-activity relationship studies on a series of 3\u03b1-[Bis(4-fluorophenyl)methoxy]tropanes and 3\u03b1-[Bis(4-fluorophenyl)methylamino]tropanes as novel atypical dopamine transporter (DAT) inhibitors for the treatment of cocaine use disorders","volume":"60","author":"Zou","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618302419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618302419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:44:13Z","timestamp":1759311853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018618302419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":108,"alternative-id":["S0197018618302419"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2018.08.008","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the benztropine analog [125I]GA II 34 binding site on the human dopamine transporter","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2018.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}